News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,823 Results
Type
Article (86591)
Company Profile (702)
Press Release (761530)
Multimedia
Podcasts (134)
Webinars (16)
Section
Business (232725)
Career Advice (4128)
Deals (39730)
Drug Delivery (129)
Drug Development (91007)
Employer Resources (198)
FDA (18133)
Job Trends (17345)
News (396562)
Policy (39766)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (96)
Alliances (56876)
ALS (108)
Alzheimer's disease (1522)
Antibody-drug conjugate (ADC) (167)
Approvals (18075)
Artificial intelligence (352)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (90)
Brain cancer (33)
Breast cancer (329)
Cancer (2588)
Cardiovascular disease (219)
Career advice (3535)
Career pathing (34)
CAR-T (187)
Cell therapy (524)
Cervical cancer (22)
Clinical research (73639)
Collaboration (964)
Company closure (2)
Compensation (603)
Complete response letters (30)
COVID-19 (2881)
CRISPR (58)
C-suite (290)
Cystic fibrosis (112)
Data (2530)
Decentralized trials (2)
Denatured (47)
Depression (58)
Diabetes (314)
Diagnostics (6943)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (160)
Drug pricing (140)
Drug shortages (34)
Duchenne muscular dystrophy (113)
Earnings (97370)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130588)
Executive appointments (826)
FDA (19638)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (874)
Gene editing (134)
Generative AI (36)
Gene therapy (391)
GLP-1 (873)
Government (5185)
Grass and pollen (6)
Guidances (178)
Healthcare (20895)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Immuno-oncology (2)
Indications (31)
Infectious disease (3047)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (61)
Intellectual property (106)
Interviews (813)
IPO (17856)
IRA (52)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (49)
Layoffs (570)
Leadership (24)
Legal (10121)
Liver cancer (82)
Lung cancer (366)
Lymphoma (174)
Machine learning (9)
Management (65)
Manufacturing (389)
MASH (88)
Medical device (14660)
Medtech (14665)
Mergers & acquisitions (22485)
Metabolic disorders (842)
Multiple sclerosis (93)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2173)
NextGen: Class of 2025 (7683)
Non-profit (5084)
Now hiring (43)
Obesity (447)
Opinion (279)
Ovarian cancer (86)
Pain (107)
Pancreatic cancer (91)
Parkinson's disease (173)
Partnered (25)
Patents (268)
Patient recruitment (127)
Peanut (51)
People (65427)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22730)
Phase II (31992)
Phase III (24070)
Pipeline (1542)
Policy (190)
Postmarket research (3552)
Preclinical (10272)
Press Release (72)
Prostate cancer (118)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (458)
Real estate (7394)
Recruiting (75)
Regulatory (26886)
Reports (61)
Research institute (2661)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (9)
RSV (51)
Schizophrenia (84)
Series A (151)
Series B (100)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4296)
State (2)
Stomach cancer (16)
Supply chain (77)
Tariffs (59)
The Weekly (85)
Vaccines (836)
Venture capitalists (47)
Weight loss (310)
Women's health (42)
Worklife (20)
Date
Today (154)
Last 7 days (739)
Last 30 days (4009)
Last 365 days (35503)
2025 (14362)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (64)
Alaska (7)
Arizona (273)
Arkansas (14)
Asia (50238)
Australia (8847)
California (7041)
Canada (2184)
China (604)
Colorado (301)
Connecticut (317)
Delaware (175)
Europe (115319)
Florida (1030)
Georgia (239)
Hawaii (1)
Idaho (65)
Illinois (666)
India (31)
Indiana (355)
Iowa (13)
Japan (190)
Kansas (115)
Kentucky (29)
Louisiana (16)
Maine (72)
Maryland (1020)
Massachusetts (5365)
Michigan (261)
Minnesota (444)
Mississippi (3)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (75)
New Hampshire (72)
New Jersey (1954)
New Mexico (31)
New York (1973)
North Carolina (1181)
North Dakota (10)
Northern California (3029)
Ohio (236)
Oklahoma (15)
Oregon (48)
Pennsylvania (1519)
Puerto Rico (15)
Rhode Island (36)
South America (1653)
South Carolina (30)
South Dakota (1)
Southern California (2599)
Tennessee (113)
Texas (1054)
United States (26683)
Utah (205)
Virginia (192)
Washington D.C. (74)
Washington State (637)
West Virginia (4)
Wisconsin (76)
There are 848,823 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Brazil GMP Approval Enhances BioDlink’s Emerging Market Momentum
May 22, 2025
·
1 min read
Press Releases
aptaTargets transferred ApTOLL to Merck KGaA, Darmstadt, Germany
ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck KGaA, Darmstadt, Germany, to assume clinical development and commercialization of ApTOLL.
May 22, 2025
·
1 min read
Job Trends
Exit Strategy: Biopharma Pros Look Outside Industry—and US
A
BioSpace
survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some are also seriously thinking about leaving the U.S. to find employment in the field.
May 22, 2025
·
6 min read
·
Angela Gabriel
Press Releases
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron’s $256M 23andMe Acquisition
May 22, 2025
·
5 min read
Press Releases
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
May 22, 2025
·
5 min read
Press Releases
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
May 22, 2025
·
2 min read
Press Releases
ulrich medical USA® Appoints Eric Gibbs as President and General Manager
May 22, 2025
·
2 min read
Press Releases
Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate
May 22, 2025
·
2 min read
Press Releases
Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting
May 22, 2025
·
5 min read
IN PARTNERSHIP WITH IQVIA
How Target Product Profiles Guide the Industry Through Uncertain Times
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.
May 22, 2025
·
1 min read
·
Lori Ellis
1 of 84,883
Next
